Explore more publications!

Healthcare Wire Texas: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Wire Texas.

Press releases published on November 21, 2025

CodaPet expands compassionate in-home pet euthanasia services in Plano, TX
PitPat Announces the November Elite Challenge: A Global 20KM Showdown Bringing Runners Together on the Digital Stage
C3HIE and Texas Health Services Authority Finalize Statewide Bidirectional Data-Sharing Agreement
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Conavi Medical Corp. Announces Proposed Public Offering of Common Shares and Pre-Funded Warrants
Teva to Present at the 8th Annual Evercore Healthcare Conference, the Piper Sandler 37th Annual Healthcare Conference and Citi’s 2025 Global Healthcare Conference in December
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Olema Oncology to Participate in 8th Annual Evercore Healthcare Conference
Supernus Pharmaceuticals to Participate in the Piper Sandler 37th Annual Healthcare Conference
Echo IQ to Participate in the Piper Sandler 37th Annual Healthcare Conference
Inventiva reports 2025 Third Quarter Financial Information¹
Inventiva publie ses informations financières du 3ème trimestre 2025¹
Scilex Holding Company Announces Update Regarding Distribution of Dream Bowl 2026 Meme Coin by Datavault AI Inc.
TrialWire’s™ Industry Leading AI-powered Patient Recruitment Platform Delivers Continuous Clinical Trial Referrals over Holiday Season
Denied During Shutdown? Allsup Offers Expert Appeals Advocacy For SSDI Claimants As SSA Resumes Normal Operations
NewHealthInsurance.com Urges Americans to Review Coverage Options as Open Enrollment Window Closes Soon
Brain Injury Association of America Honored Centre for Neuro Skills’ Dr. Mark Ashley as Luminary of the Year
Dr. Zachary Solomon Launches the Medical Tech Grant to Advance Innovation in Healthcare and Technology
Pasithea Therapeutics Announces Positive PAS-004 Tablet Pharmacokinetic (PK) Data in Ongoing Phase 1/1b Trial in Adult NF1 Patients
Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions